CD276 and glioblastoma: Using this powerful new technology, we have specifically studied the tissue distribution of Iba1+ and CD163-expressing macrophages in human glioblastoma biopsies in relation to CD276+ GSCs, with the aim of gaining insights into their in situ relationship.